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Abstract 
A wireless programmable electronic platform for implantable monitoring of blood glucose level (BGL) was developed and 
preliminary tested on bench. This system allows extremely low power bidirectional telemetry, based on the IEEE802.15.4-2003 
protocol, thus enabling typical battery lifetime up to six months and wireless networking of multiple sensors. During a single 
BGL measurement, the circuit drives a laser diode, for sensor excitation, and acquires the amplified signals coming from four 
different photodetectors. The electronics is designed to be integrated in a complete system for BGL monitoring to be implanted 
for at least six months under the skin of diabetic patients. 
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1. Introduction 
 
The application of implantable wireless devices for chronic monitoring of life threatening parameters is nowadays 
expanding thanks to novel low power technologies for biotelemetry [1]. Devices based on the IEEE 802.15.4-2003 
protocol are able to last up to several years without a battery replacement [2]. Thanks to the availability of 
miniaturized components combined with advanced packaging techniques, dimensions of wireless electronics can be 
scaled down to implantable size [3]. The present work reports about a miniaturized implantable BGL monitoring 
device [4], focusing on the wireless electronic platform. Main requirements for this sub-unit are low power 
consumption, reduced dimensions, an adequate number of analog input, a safe level of radio frequency energy 
across the human body and a low cost. In order to meet all these requirements at once, the CC2430 from Texas 
Instruments Inc. was selected as core component of the telemetry platform. This device embeds an 8051 
programmable microcontroller together with an IEEE 802.15.4-2003 compatible transceiver in a 7 x 7 mm
2
 package. 
 
2. System Overview 
 
The detection principle is based on change of fluorescence resonant energy transfer (FRET) efficiency of a 
synthesized protein as a function of analyte concentration. The proteins are immobilized inside a hydrogel 
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waveguide [5] and are excited with a laser diode coupled to the waveguide. Along the waveguide four photodiodes 
with optical filters are placed to detect the fluorescent signals. The current signals of the detectors are amplified and 
converted into voltage signals in the range between 0.9V and 3.8V. The microcontroller is programmed to switch on 
the laser diode through a proper driving circuit and to sample the four amplified signals coming from the 
photodiodes. Signals are acquired at 10 kHz and then averaged on board over 256 samples in order to get stable 
values. The sensing part can be disabled by the microcontroller through a switch in order to save power during idle 
mode. System architecture and typical measurement timing are reported in Fig. 1 and Fig. 2 respectively. 
 
 
Fig. 1: System architecture of the implant. 
 
 
Fig. 2: Detailed view of the measurement timing. 
 
On the user side, a purposely developed transceiver interfaces the implant with the Universal Serial Bus (USB) 
port of a standard Personal Computer (PC). This transceiver embeds a CC2430 and a serial to USB converter 
(UM232, FTDI, UK). Each device is identified by a unique address, so that several implantable sensors can be 
monitored at once by the same external unit. Being this architecture based on a ZigBee [6] compliant hardware, a 
wireless sensor network scenario can be easily implemented. This would allow the on line monitoring of a huge 
number of patients (up to 65536) thanks to the 16-bit addressing of the ZigBee stack. 
In the present work, a Human Machine Interface (HMI) was developed in Labview 8.2 (National Instruments 
Inc., USA). This HMI enables the user to set the measurement parameters and to communicate with the implant. 
Acquired BGL samples are visualized on screen and stored in a spreadsheet file for future use. 
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 3. Results and discussion 
 
Preliminary tests showed a battery lifetime up to six months by sampling BGL every 15 minutes and by using a 
specially designed miniature cell from Tadiran Batteries with 350mAh. Thanks to a proper selection of the single 
components, the electronics can be scaled down in dimensions to be located within two miniaturized boards, being 
17 mm and 13 mm in diameter each. The implant concept design, being 50 mm in length and 20 mm in diameter, is 
represented in Fig. 3. The system was preliminarily characterized by cycling between maximum and minimum 
signal levels achieved by addition and removal of Ca
2+
. Typical acquired plots are reported in Fig. 4. 
 
 
Fig. 3: Implant concept design, final devised dimensions: length 50 mm, diameter 20 mm. 
 
 
Fig. 4: Signals from the photodiodes in response to FRET changes in the measurement chamber. The changes were induced by 
flushing the measurement chamber and alternating solutions of CaCl2 and EDTA. Signal from YFP decreases with EDTA-caused 
loss of FRET, while signal from CFP increases. CaCl2 has the opposite effect. 
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